MedPath
FDA Approval

Blenrep

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
GlaxoSmithKline LLC
DUNS: 167380711
Effective Date
February 28, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Belantamab mafodotin(50 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Blenrep

Product Details

NDC Product Code
0173-0896
Application Number
BLA761158
Marketing Category
BLA (C73585)
Route of Administration
INTRAVENOUS
Effective Date
February 28, 2022
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
Code: DB1041CXDGClass: ACTIBQuantity: 50 mg in 1 mL
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
TREHALOSE DIHYDRATEInactive
Code: 7YIN7J07X4Class: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
© Copyright 2025. All Rights Reserved by MedPath